跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 25 条关于
“Vascarta”
全部
25
临床试验
9
药物
3
机构
0
资讯
13
11个月前
Vascarta Completes Phase 1 Trial of Topical Curcumin Gel VAS-101 for Knee Osteoarthritis
去年
Vascarta Launches First Human Trial of Transdermal Curcumin Therapy for Sickle Cell Disease
去年
Vascarta's Vasceptor Receives FDA Orphan Drug Designation for Sickle Cell Disease Treatment
10个月前
Vascarta's STO-1 Achieves 67% Survival Rate in Preclinical Glioblastoma Study
5个月前
Vascarta's Topical Curcumin Gel VAS-101 Shows Significant Pain Reduction in Knee Osteoarthritis Phase 1b Trial
去年
Yescarta Shows Sustained Efficacy in Relapsed/Refractory Large B-Cell Lymphoma
去年
Experts Debate CAR T-Cell Therapy Options: Comparing Yescarta and Breyanzi for Lymphoma Treatment
去年
Real-World Data Shows Yescarta CAR-T Therapy Safe and Effective in Outpatient Setting
去年
Yescarta Approved in Scotland as First Second-Line CAR-T Therapy for DLBCL
去年
CAR-T Therapy Yescarta and Quizartinib Approved for Blood Cancers on NHS Scotland
第 1 页,共 2 页
上一页
下一页